CD276 and desmoplastic small round cell tumor: In fact, a monoclonal antibody against B7-H3 (NCT02982941) and two radionuclide-labeled monoclonal antibodies against B7-H3 (NCT04022213) and GD2 (NCT00445965) are currently being tested in clinical trials open to patients with DSRCT.